|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.790 USD | +2.43% |
|
+7.06% | +9.22% |
| 19/03 | Prime Medicine, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 02:15 PM | |
| 12/03 | Oppenheimer Initiates Prime Medicine at Outperform With $11 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 671M | - | ||||
| 52.12B | |||||
| 47.25B | |||||
| 31.67B | - | ||||
| 25.15B | - | ||||
| 19.54B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition